Session # 01: Common Diseases of Gastro Intestinal Tract

Sub-Session 1: Navigating the evolving landscape of GERD: From pathophysiology to precision therapy.

Sub-Session 2: Innovation and balance: Latest insights and clinical applications of acid-suppressive therapies.

Sub-Session 3: Innovative approaches in functional dyspepsia: From mechanisms to multimodal management.

Sub-Session 4: Diagnostic and therapeutic approaches to refractory functional gastrointestinal symptoms.

Session # 02: Gastro Intestinal Endoscopy

Sub-Session 1: Precision diagnostics in upper GI endoscopy: The role of artificial intelligence.

Sub-Session 2: Clinical practice guidelines for upper GI endoscopy: Case based learning.

Sub-Session 3: Advancing therapeutic endoscopy techniques.

Sub-Session 4: Recent updates in the endoscopic diagnosis and management of pancreatic cysts.

Session # 03: Pancreatitis

Sub-Session 1: Autoimmune pancreatitis: Cornerstones and future perspectives.

Sub-Session 2: Managing complications of chronic pancreatitis: a guide for the gastroenterologist.

Sub-Session 3: The interaction of microbiome and pancreas in acute pancreatitis.

Sub-Session 4: Groove pancreatitis: from enigma to future directions.

Session # 04: Bowel Disorders

Sub-Session 1: Advancing IBD care: Translating research into clinical practice.

Sub-Session 2: Innovations in endoscopic management of IBD.

Sub-Session 3: Comprehensive strategies in IBS management: From pathophysiology to practice.

Sub-Session 4: Emerging trends in constipation treatment: From microbiota to modern therapeutics.

Session # 05: Colonoscopy

Sub-Session 1: Latest advances in diagnostic and therapeutic colonoscopy for challenging situations.

Sub-Session 2: Adverse events related to colonoscopy: Global trends and future challenges.

Sub-Session 3: Optimization of colonoscopy quality: Comprehensive review of the literature and future perspectives.

Sub-Session 4: AI for colonoscopy and intestinal diseases: The road ahead.

Session # 06: Liver Disorders

Sub-Session 1: Special considerations for liver diseases in distinct conditions.

Sub-Session 2: Biomarkers for diagnosis, treatment response, and prognosis in liver diseases.

Sub-Session 3: Guidelines and evidence-based recommendations in liver disease management.

Sub-Session 4: Early predictors of hepatitis B relapse after antiviral cessation.

Session # 07: Gastro Intestinal Tract Cancer

Sub-Session 1: Novel biomarkers and strategies in early diagnosis of gastrointestinal cancers.

Sub-Session 2: Pancreatic ductal adenocarcinoma: Insights from genomics to clinical implications.

Sub-Session 3: Focused management strategies in gastrointestinal cancer.

Sub-Session 4: Innovative strategies in gastroesophageal cancer therapy: Precision medicine, resistance, and emerging technologies.

Session # 08: ERCP

Sub-Session 1: Ensuring safety and effectiveness in ERCP: Case-based approaches with technical insights.

Sub-Session 2: ERCP in the management of biliary complications after cholecystectomy.

Sub-Session 3: Clinical practice guideline for post-ERCP pancreatitis.

Sub-Session 4: Current challenges in pediatric ERCP.

Session # 09: Gastrointestinal Bleeding

Sub-Session 1: Managing antiplatelet and anticoagulation: Therapy in the peri-endoscopic period.

Sub-Session 2: Management of nonvariceal upper GI bleeding: Choosing the right tool.

Sub-Session 3: Lower GI bleeding: Role of the endoscopist and a treatment algorithm.

Sub-Session 4: Investigating and managing small bowel bleeding.

Session # 10: Gastroduodenal Diseases

Sub-Session 1: Autoimmune gastritis, eosinophilic gastroduodenitis: New advances in diagnosis and therapy.

Sub-Session 2: The evolution of gastroparesis as a sensorimotor disorder: It's on the spectrum.

Sub-Session 3: Artificial nutrition support in disorders of gut-brain interaction: What, when, why not?

Sub-Session 4: Complex case discussion.

Session # 11: Colorectal Cancer

Sub-Session 1: Exploring the latest advances in colorectal cancer prevention and screening.

Sub-Session 2: Optimal treatment strategies for rectal cancer.

Sub-Session 3: Current insights and future directions in colorectal neoplasia: Pathogenesis, detection and therapy.

Sub-Session 4: Genetic and biological hallmarks of colorectal cancer.

Session # 12: Peptic Ulcer Disease

Sub-Session 1: The shifting etiology of PUD: Moving beyond H. pylori and NSAIDs to include idiopathic ulcers.

Sub-Session 2: Global trends in PUD burden: Analyzing declining prevalence alongside rising complications in specific regions

Sub-Session 3: Confronting antimicrobial resistance: Updated, effective, and evidence-based quad therapy for H. pylori eradication.

Sub-Session 4: Management of refractory PUD: Treatment approaches for ulcers that fail to heal after standard therapy.